Therapeutic strategies for triple-negative breast cancer, Cancer J, vol.14, pp.343-51, 2008. ,
Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas, Int J Cancer, vol.51, pp.548-54, 1992. ,
Generation of multicellular tumor spheroids by the hanging-drop method, Methods Mol Med, vol.140, pp.141-51, 2007. ,
Aberrant splicing and protease involvement in mesothelin release from epithelioid mesothelioma cells, Cancer Sci, vol.99, pp.590-594, 2008. ,
Mesothelin is not required for normal mouse development or reproduction, Mol Cell Biol, vol.20, pp.2902-2908, 2000. ,
Mesothelin immunotherapy for cancer: ready for prime time?, J Clin Oncol, vol.34, pp.4171-4180, 2016. ,
The role of mesothelin in tumor progression and targeted therapy, Anticancer Agents Med Chem, vol.13, pp.276-80, 2013. ,
Mesothelin promotes anchorageindependent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells, Mol Cancer Res, vol.6, pp.186-93, 2008. ,
Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients, Clin Cancer Res, vol.18, pp.2478-89, 2012. ,
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors, Mol Cancer, vol.5, p.50, 2006. ,
Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation, Sci Rep, vol.3, p.1870, 2013. ,
Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter, Hum Pathol, vol.41, pp.1330-1338, 2010. ,
Stromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57mg mouse mammary epithelial cells, BMC Dev Biol, vol.3, issue.2, 2003. ,
Novel antibody therapeutics targeting mesothelin in solid tumors, Clin Cancer Drugs, vol.3, pp.76-86, 2016. ,
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses, JCI Insight, vol.3, p.99573, 2018. ,
Amatuximab and novel agents targeting mesothelin for solid tumors, Onco Targets Ther, vol.10, pp.5337-53, 2017. ,
, Breast Cancer Res Treat, vol.133, pp.799-804, 2012.
Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival, PLoS ONE, vol.9, p.114900, 2014. ,
Mesothelin expression is associated with poor outcomes in breast cancer, Breast Cancer Res Treat, vol.147, pp.675-84, 2014. ,
Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers, Biomed Pharmacother, vol.70, pp.190-195, 2015. ,
Single-domain antibody-based and linker-free bispecific antibodies targeting FcgammaRIII induce potent antitumor activity without recruiting regulatory T cells, Mol Cancer Ther, vol.12, pp.1481-91, 2013. ,
A FcgammaRIIIengaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy, Oncotarget, vol.5, pp.5304-5323, 2014. ,
Anti-mesothelin nanobodies for both conventional and nanoparticlebased biomedical applications, J Biomed Nanotechnol, vol.11, pp.1201-1213, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01450786
Isolation and characterization of anti-FcgammaRIII (CD16) llama singledomain antibodies that activate natural killer cells, Protein Eng Des Sel, vol.21, pp.1-10, 2008. ,
Spheroid-based drug screen: considerations and practical approach, Nat Protoc, vol.4, pp.309-333, 2009. ,
Targeted therapy for metastatic triple negative breast cancer: the next frontier in precision oncology, Oncotarget, vol.8, pp.106167-106175, 2017. ,
Inhibition of mesothelin as a novel strategy for targeting cancer cells, PLoS ONE, vol.7, p.33214, 2012. ,
Mesothelin-targeted agents in clinical trials and in preclinical development, Mol Cancer Ther, vol.11, pp.517-542, 2012. ,
Immunohistochemical categorisation of ductal carcinoma in situ of the breast, Br J Cancer, vol.98, pp.137-179, 2008. ,
The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis, Oncol Lett, vol.14, pp.5865-70, 2017. ,
Tumor cellproduced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer, Oncotarget, vol.5, pp.2736-2785, 2014. ,
Efficacy of catumaxomab in tumor spheroid killing is mediated by its trifunctional mode of action, Cancer Immunol Immunother, vol.59, pp.1675-84, 2010. ,
Multicellular spheroids: a threedimensional in vitro culture system to study tumour biology, Int J Exp Pathol, vol.79, pp.1-23, 1998. ,
Preparation strategy and illumination of three-dimensional cell cultures in light sheet-based fluorescence microscopy, J Biomed Opt, vol.17, p.101518, 2012. ,
High-resolution deep imaging of live cellular spheroids with light-sheet-based fluorescence microscopy, Cell Tissue Res, vol.352, pp.161-77, 2013. ,
Efficient Bayesian-based multiview deconvolution, Nat Methods, vol.11, pp.645-653, 2014. ,
Dynamics of NK cell interactions in vivo, Immunol Rev, vol.251, pp.154-163, 2013. ,
Serial killing of tumor cells by human natural killer cells-enhancement by therapeutic antibodies, PLoS ONE, vol.2, p.326, 2007. ,
Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation, Proc Natl Acad Sci, vol.108, pp.728-760, 2011. ,
Fcoptimized NKG2D-Fc constructs induce NK cell antibody-dependent cellular cytotoxicity against breast cancer cells independently of HER2/neu expression status, Cold Spring Harb Perspect Biol, vol.193, p.28480, 2014. ,
Regulation of human NKcell cytokine and chemokine production by target cell recognition, Blood, vol.115, pp.2167-76, 2010. ,
Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer, J Exp Clin Cancer Res, vol.35, p.39, 2016. ,
CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes, Sci Rep, vol.6, p.34310, 2016. ,
Human neutrophils express low levels of FcgammaRIIIA, which plays a role in PMN activation, Blood, vol.133, pp.1395-405, 2019. ,
CD16A activation of NK cells promotes NK cell proliferation and memory-like cytotoxicity against cancer cells, Cancer Immunol Res, vol.6, pp.517-544, 2018. ,
Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer, Expert Opin Biol Ther, vol.15, pp.1093-1102, 2015. ,
Antiserum albumin domain antibodies for extending the half-lives of short lived drugs, Protein Eng Des Sel, vol.21, pp.283-291, 2008. ,
MorphoLibJ: integrated library and plugins for mathematical morphology with, ImageJ. Bioinformatics, vol.32, pp.3532-3536, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01438611